CALL/ABBOTT LABORATORIES/140/0.1/21.06.24 Stock

Warrant

DE000GX8Z2M7

Market Closed - BOERSE MUENCHEN 02:27:28 2024-06-11 pm EDT
0.003 EUR -50.00% Intraday chart for CALL/ABBOTT LABORATORIES/140/0.1/21.06.24
3 months-92.50%
6 months-80.00%
Date Price Change
24-06-11 0.003 -50.00%
24-06-10 0.006 +50.00%
24-06-07 0.004 +33.33%
24-06-06 0.003 +50.00%
24-06-05 0.002 -33.33%

Real-time BOERSE MUENCHEN

Last update June 11, 2024 at 02:27 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer Goldman Sachs
WKN GX8Z2M
ISINDE000GX8Z2M7
Date issued 2022-09-06
Strike 140 $
Maturity 2024-06-21 (10 Days)
Parity 10 : 1
Emission price 0.43
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.71
Lowest since issue 0.002
Spread 0.03
Spread %96.77%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
105.8 USD
Average target price
125.4 USD
Spread / Average Target
+18.49%
Consensus